Committees

Committee members play a critical role in providing FDLI with subject-matter and editorial advisory expertise. Service on committees is limited to FDLI members and government employees. 

Get Involved: Become an FDLI Member

2020 FDLI Committees

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments.

  • Melissa Scales (Staff Liaison), FDLI
  • Fadwa Almanakly, Bayer Healthcare Pharmaceuticals
  • Heather Banuelos, (Co-Chair), King & Spalding LLP 
  • Madhavi Bellamkonda, Abbott Vascular
  • Blythe Buchanan, Biogen, Inc.
  • Rebecca Burnett, Framework Solutions
  • Dale Cooke, PhillyCooke Consulting
  • Mary Ellen Dronitsky, Northeastern University
  • Virginia Foley, Opus Regulatory Inc
  • Mark Garsombke, Hall, Render, Killian, Heath & Lyman P.C.
  • Bryant M. Godfrey, Arnold & Porter LLP
  • Mark C. Levy, Eckert Seamans Cherin & Mellott, LLC
  • Lauren A. Miller, Otsuka America Pharmaceutical, Inc.
  • Cassie Scherer, Medtronic
  • Dolores M. Shank-Samiec, (Co-Chair), Merck & Co., Inc. 
  • Michael Francis Smith, Michael F. Smith Law, PLLC

Annual Conference Planning Committee helps FDLI develop the premier conference for the food and drug law industry.

  • Laura Brown (Staff Liaison), FDLI
  • Wade Ackerman, Covington & Burling LLP
  • David Bloch, Medtronic
  • Jeff Chasnow, Pfizer, Inc.
  • James N. Czaban (Co-Chair), Loeb & Loeb LLP
  • Sandra Eskin, Pew Charitable Trusts
  • Azim Chowdhury, Keller and Heckman LLP
  • Kathleen Hoke, University of Maryland Carey School of Law
  • Jonathan Havens, Saul Ewing Arnstein & Lehr LLP
  • Erika Lietzan, University of Missouri-Columbia School of Law
  • John A. Murphy, Biotechnology Innovation Organization
  • Adora Ndu (Co-Chair),  BioMarin Pharmaceutical Inc. 
  • Meredith Olearchik, Campbell Soup Company
  • Suzan Onel,  Kleinfeld, Kaplan & Becker LLP
  • Stuart Pape, Polsinelli
  • Lauren Roth, Office of the Commissioner, FDA
  • Deborah Shelton, Arent Fox LLP
  • David Spangler, Consumer Healthcare Products Association 
  • Marta Villaraga, Exponent, Inc.
  • Armando Zamora, Office of Regulatory Affairs, FDA

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors. 

  • Hayley Carpenter (Staff Liaison), FDLI
  • Cathy Burgess (Chair), Alston & Bird LLP
  • Neil P. Di Spirito, Epstein Becker & Green, PC
  • Jonathan Havens, Saul Ewing Arnstein & Lehr LLP
  • Stuart Pape, Polsinelli PC

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field. 

  • Paige Samson (Staff Liaison), FDLI
  • Alena M. Allen, University of Memphis
  • Nathan Beaton, Latham & Watkins LLP
  • Barbara A. Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Christine E. Kirk , Peterson Wilmarth and Robertson, LLP
  • Donnelly McDowell, Kelley Drye & Warren LLP
  • Joshua Oyster, Ropes & Gray LLP
  • Melissa B. Runsten, Debevoise & Plimpton, LLP

California Programs Planning Committee helps FDLI develop programming to be offered in California.

  • Khara Minter (Staff Liaison), FDLI
  • Afia Asamoah, Google Health
  • Michele L. Buenafe, Morgan, Lewis & Bockius LLP
  • Scott L. Cunningham, Covington & Burling LLP
  • Allison Fulton, Sheppard Mullin Richter & Hampton LLP
  • Vinita Kailasanath, Arnold & Porter LLP
  • Angela Meyer, Exponent
  • Amy Speros, Latham & Watkins LLP
  • Deborah E. Tolomeo, Genentech, Inc.
  • Daron Watts, The Watts Group, PLLC
  • Nury Yoo, Keller and Heckman LLP

Cannabis-Derived Products Committee assists FDLI with developing content and identifying stakeholders to contribute to the discussion of cannabis-derived products in the federal regulatory space.

  • Melissa Scales (Staff Liaison), FDLI
  • Libby Baney, Faegre Drinker
  • Linda D. Bentley, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Kelly Fair, Canopy Growth Corporation
  • William A. Garvin, Buchanan Ingersoll & Rooney PC
  • Steven N. Levine, Husch Blackwell LLP
  • Brian J. Malkin, Arent Fox LLP
  • Keith Matthews, Wiley LLP
  • Daniel McGee, Solari Hemp
  • Douglas MacKay, CV Sciences
  • Debby Miran, Entourage Therapeutics, LLC
  • Heike Newman, Senior Regulatory Manager, University of Colorado
  • Megan L. Olsen, Council for Responsible Nutrition
  • Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
  • Deborah Walter, Greenwich Biosciences
  • Daniel Wang, Pinney Associates, Inc.
  • Jessica Anne Wasserman, Greenspoon Marder LLP

 

  • Laura Brown (Staff Liaison), FDLI
  • A.J. Day, Professional Compounding Centers of America
  • Julie Dohm, CDER, FDA
  • Andrew Harrison, Hall, Render, Killian, Heath & Lyman P.C.
  • Karla Palmer, Hyman, Phelps & McNamara, PC
  • Rachael G. Pontikes, Reed Smith LLP
  • Lee Rosebush, BakerHostetler
  • Eli Zachary Tomar, Akin Gump Strauss Hauer & Feld LLP

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance.

  • Laura Brown (Staff Liaison), FDLI
  • Hannah Bornstein, Nixon Peabody LLP
  • Adrienne Franco Busby, Faegre Drinker
  • Maya P. Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • Sonali P. Gunawardhana, Shook, Hardy & Bacon LLP
  • Stephanie Haggarty, Pfizer, Inc.
  • Dan G. Jarcho, Alston & Bird LLP
  • Steven A. Johnson, Zogenix, Inc.
  • Charles N. Jolly, Baker Donelson
  • Pete J. Leininger, King & Spalding LLP
  • Anne K. Miller, Medtronic
  • Sun “Sandra” Park, Genentech, Inc.
  • Bob A. Rhoades, Validant
  • Suzie Loonam Trigg, Haynes and Boone LLP
  • Anne K. Walsh, Hyman, Phelps & McNamara, PC
  • Beth P. Weinman, Ropes & Gray LLP
  • Fran Zipp, Lachman Consultants

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors. 

  • Hayley Carpenter (Staff Liaison), FDLI
  • Frederick R. Ball (Chair), Duane Morris LLP
  • Jeffrey Francer (Board Liaison), Association for Accessible Medicines
  • Jeffery Gibbs, Hyman, Phelps & McNamara, PC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. 

  • Steven Leslie (Staff Liaison), FDLI
  • Jose Alberto Campos Vargas, Sanchez Devanny
  • Jonathan M. Cohen, K&L Gates LLP
  • Stefanie Jill Fogel, DLA Piper LLP (US)
  • Lorie S. Foster, Abbott Nutrition
  • August T. Horvath (Chair), Foley Hoag LLP
  • Maia Kats, Kaplan Fox & Kilsheimer, LLP
  • Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
  • Amy Mozingo, GRAS Associates, a Nutrasource Company
  • Eve Pelonis, Keller and Heckman LLP
  • Michael Roberts, UCLA School of Law
  • Lanny Schimel, Kerry, Inc
  • Kurt D. Weaver, Womble Bond Dickinson (US) LLP

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions, advises on content, and serves as a resource for our student editors at Georgetown University Law Center.

  • Paige Samson (Staff Liaison), FDLI
  • Nigel Barrella, The Good Food Institute 
  • Laurie J. Beyranevand, Vermont Law School
  • Jennifer Black, OC, FDA
  • Marie Boyd, University of South Carolina
  • Nathan Brown, Akin Gump Strauss Hauer & Feld LLP
  • Bridget C.E. Dooling, George Washington University
  • Carl Fischer, Becton Dickinson (BD)
  • Lewis Grossman, American University
  • Peter Barton Hutt, Covington & Burling LLP
  • John Johnson III,Shook, Hardy & Bacon LLP
  • Alan C. Katz, toXcel, LLC
  • Dinesh Kumar,OC, FDA
  • Marian J. Lee, Gibson Dunn & Crutcher LLP
  • Priya Malavika Mannan, Novartis Pharmaceuticals Corporation
  • J. R. McNair, Winston & Strawn LLP
  • Alan G. Minsk, Arnall Golden Gregory LLP
  • Anne Marie Murphy, Consumer Healthcare Products Association (CHPA)
  • Nicole Negowetti, Harvard Law School
  • James T. O’Reilly, (Chair), University of Cincinnati
  • Joseph A. Page (Academic Advisor), Georgetown University
  • Sung Park, Reed Smith LLP
  • Jessica Ringel, King & Spalding LLP
  • Marc J. Scheineson, Alston & Bird LLP
  • Shy Shorer, National Institutes of Health
  • Anna Sims,OC, FDA
  • Eric Solowey, Parexel International Corporation
  • Andrew Wasson, Haug Partners LLP
  • Emily Wright, Pfizer, Inc.
  • Patti Zettler, The Ohio State University

Food Enforcement and Compliance Conference Planning Committee helps FDLI to cover recent changes and updates in food enforcement and compliance. 

  • Steve Leslie (Staff Liason), FDLI
  • Elizabeth Fawell, Hogan Lovells
  • John Packman, DLA Piper
  • Sarah Roller, Kelley Drye & Warren
  • Steve Armstrong, Haynes & Boon, LLP
  • Ricardo Carvajal, Hyman Phelps & McNamara
  • Andrea Ferrenz, Campbell Soup
  • Dana Graber, FMI
  • Heili Kim, Faegre Drinker Biddle & Reath LLP
  • Trevor Findley, USDA

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.  

  • Melissa Scales (Staff Liaison), FDLI
  • Shelby Buettner, OC, FDA
  • Melanie Katrice Gross, Genentech, Inc. 
  • Ralph F. Hall, University of Minnesota
  • Colleen M. Heisey, Jones Day
  • Carmine Jabri, E.M.M.A. International Consulting Group, Inc.
  • Monaya M. Krause, Medtronic
  • Chad A. Landmon, Axinn, Veltrop & Harkrider LLP
  • Scott M. Lassman, Lassman Law + Policy
  • Gregory H. Levine, Ropes & Gray LLP
  • Veleka Peeples-Dyer, Baker McKenzie
  • Schevon Gaylord Salmon, Otsuka America Pharmaceutical, Inc.
  • Kathleen M. Sanzo, Morgan, Lewis & Bockius LLP

New to Food and Drug Law Planning Committee assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Paige Samson (Staff Liaison), FDLI
  • Alexander V. Alfano, Axinn, Veltrop & Harkrider LLP
  • Brigid Bondoc, Sidley Austin LLP
  • Delia A. Deschaine, Hogan Lovells US LLP
  • Lauren A. Farruggia, Saul Ewing Arnstein & Lehr LLP
  • Dina Gayanova, Buchanan Ingersoll & Rooney PC
  • Steven Gonzalez, Ropes & Gray LLP
  • Elizabeth Mulkey, Goodwin Procter LLP
  • Marc Wagner, BakerHostetler

Patient Organization Engagement Committee assists FDLI by creating innovative introductory course offerings for patient organizations.

  • Paige Samson (Staff Liaison), FDLI
  • Ryan Hohman, Friends of Cancer Research
  • Brenda Huneycutt, FasterCures
  • Maureen M. Japha, Peterson Wilmarth and Robertson, LLP (PWR)
  • Debra Lappin, Faegre Drinker Biddle & Reath LLP
  • Lisa Pieretti, International Hyperhidrosis Society
  • Ami E. Simunovich, Becton Dickinson (BD)
  • James Valentine, Hyman, Phelps & McNamara, PC
  • Laura D. Wingate, Crohn’s & Colitis Foundation
  • Paige Samson (Staff Liaison), FDLI
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Mark Hendrickson, Leavitt Partners
  • Laurie Lenkel, Office of the Commissioner, FDA
  • Elizabeth Richards, Latham & Watkins LLP
  • Sarah Roache, Georgetown University
  • Lynn C. Tyler, Barnes & Thornburg LLP

Publications Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters. 

  • Paige Samson (Staff Liaison), FDLI
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Royce B. DuBiner, McGuireWoods LLP
  • Emily Hussey, Reed Smith LLP
  • Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
  • Areta L. Kupchyk, Foley Hoag LLP
  • Dan Logan, Kleinfeld, Kaplan & Becker, LLP
  • Eileen M. McMahon, Torys LLP
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Beth G. Oliva, Fox Rothschild LLP
  • Neha Patel, Myovant Sciences
  • Tyler Scandalios,Benjamin L. England & Associates LLC/FDAImports.com
  • Melissa Scales (Staff Liaison), FDLI
  • Mantej (Nimi) Chhina, BioMarin Pharmaceutical Inc.
  • Catherine M. Cook, Greenleaf Health, Inc.
  • Paul Gadiock, Wilson Sonsini Goodrich & Rosati
  • Todd Halpern, Venable LLP
  • Katie Laney, Validant
  • Deborah L. Livornese, Hyman, Phelps & McNamara, PC
  • Daniel Orr, Womble Bond Dickinson (US) LLP
  • Lance L. Shea, BakerHostetler
  • Julia Tierney, CBER, FDA
  • Michael Werner, Holland & Knight LLP

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.  

  • Steven Leslie (Staff Liaison), FDLI
  • Issa Abuaita, Al Fakher USA
  • Scott D. Ballin, Public Health Consultant
  • James Baumberger*, American Academy of Pediatrics
  • Aruni Bhatnagar*, American Heart Association
  • Tara Lin Couch, EAS Consulting Group, LLC
  • Michael Cummings, Medical University of South Carolina
  • Brittani Cushman, Turning Point Brands, Inc.
  • Cliff Douglas*, American Cancer Institute
  • Stacey Younger Gagosian*, Truth Initiative
  • Thomas Glynn, Stanford University School of Medicine
  • Robyn Gougelet, Pinney Associates, Inc.
  • Ben Haas, Latham & Watkins LLP
  • Bryan M. Haynes, Troutman Sanders LLP
  • Dennis Henigan*, Campaign for Tobacco-Free Kids
  • Desmond Jenson*, Public Health Law Center – Tobacco Control Legal Consortium
  • Eshael Johnson, CTP, FDA
  • Ondrej Koumal, Philip Morris International
  • Eric N. Lindblom, O’Neill Institute for National and Global Health Law, Georgetown Law
  • Joe Murillo, JUUL Labs
  • John Marshall, Altria Client Services LLC
  • Kelley Coleman Nduom, CDER, FDA
  • Henry Roemer, Specialty Tobacco Council, Inc
  • Barry Schaevitz, Fox Rothschild LLP
  • Jim M. Solyst, Swedish Match North America
  • Mark J. Vaders, Womble Bond Dickinson (US) LLP

*Public Health Subcommittee

Webinar Programs Committee advises FDLI in formulating and implementing webinars about law, regulation and policy affecting food and dietary supplements, tobacco and nicotine, and medical products. 

  • Melissa Scales (Staff Liaison), FDLI
  • Khara Minter (Staff Liaison), FDLI
  • Benjamin Abel, McGuireWoods LLP
  • Kalah Auchincloss, Greenleaf Health, Inc.
  • Nathan Beaver, Foley & Lardner LLP
  • Mitchell Berger, CBER, FDA
  • Vanessa K. Burrows, Simpson Thacher & Bartlett
  • Karen Corallo, Skadden, Arps, Slate, Meagher & Flom LLP
  • Jack Garvey, Compliance Architects LLC
  • Abraham Gitterman, Arnold & Porter LLP
  • Elizabeth Guo, Covington & Burling LLP
  • Kendra A. Martello, Mallinckrodt Pharmaceuticals
  • Rebecca Jones McKnight, DLA Piper LLP (US)
  • Elise Paeffgen, Alston & Bird LLP
  • Serra J. Schlanger, Hyman, Phelps & McNamara, PC
  • Cicely Vaughn, Walmart Inc.
  • Carolina Wirth, Arnall Golden Gregory LLP